

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | carnitine shuttle (GO:0006853) | 6.41481099 |
| 2 | fatty acid transmembrane transport (GO:1902001) | 6.00453476 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.27869620 |
| 4 | 2-oxoglutarate metabolic process (GO:0006103) | 5.00893425 |
| 5 | tricarboxylic acid cycle (GO:0006099) | 4.90783140 |
| 6 | sarcomere organization (GO:0045214) | 4.90326651 |
| 7 | lysine catabolic process (GO:0006554) | 4.89865016 |
| 8 | lysine metabolic process (GO:0006553) | 4.89865016 |
| 9 | carnitine transmembrane transport (GO:1902603) | 4.86477628 |
| 10 | histone H3-K36 demethylation (GO:0070544) | 4.86061942 |
| 11 | cardiac myofibril assembly (GO:0055003) | 4.85396564 |
| 12 | regulation of sequestering of triglyceride (GO:0010889) | 4.82541895 |
| 13 | amino-acid betaine transport (GO:0015838) | 4.61198084 |
| 14 | carnitine transport (GO:0015879) | 4.61198084 |
| 15 | nuclear pore complex assembly (GO:0051292) | 4.60630713 |
| 16 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.57115806 |
| 17 | myofibril assembly (GO:0030239) | 4.53830661 |
| 18 | actin-myosin filament sliding (GO:0033275) | 4.53415574 |
| 19 | muscle filament sliding (GO:0030049) | 4.53415574 |
| 20 | regulation of histone H3-K27 methylation (GO:0061085) | 4.50185409 |
| 21 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.48826893 |
| 22 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.38502147 |
| 23 | regulation of skeletal muscle contraction (GO:0014819) | 4.31181378 |
| 24 | plasma membrane repair (GO:0001778) | 4.30159340 |
| 25 | regulation of fatty acid oxidation (GO:0046320) | 4.29131532 |
| 26 | * regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.26172448 |
| 27 | biotin metabolic process (GO:0006768) | 4.20519131 |
| 28 | valine metabolic process (GO:0006573) | 4.16968908 |
| 29 | fatty acid beta-oxidation (GO:0006635) | 4.12647140 |
| 30 | mannose metabolic process (GO:0006013) | 4.07894324 |
| 31 | negative regulation of histone methylation (GO:0031061) | 4.05621796 |
| 32 | regulation of fatty acid beta-oxidation (GO:0031998) | 4.02532483 |
| 33 | positive regulation of fatty acid oxidation (GO:0046321) | 3.98368750 |
| 34 | aspartate family amino acid catabolic process (GO:0009068) | 3.92611653 |
| 35 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.91807068 |
| 36 | pre-miRNA processing (GO:0031054) | 3.91000156 |
| 37 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.89495402 |
| 38 | regulation of RNA export from nucleus (GO:0046831) | 3.84662019 |
| 39 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.82734967 |
| 40 | tricarboxylic acid metabolic process (GO:0072350) | 3.82058101 |
| 41 | creatine metabolic process (GO:0006600) | 3.79594231 |
| 42 | acetyl-CoA metabolic process (GO:0006084) | 3.79516127 |
| 43 | * regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.74338779 |
| 44 | actin-mediated cell contraction (GO:0070252) | 3.72709683 |
| 45 | cardiac muscle contraction (GO:0060048) | 3.71312778 |
| 46 | alpha-linolenic acid metabolic process (GO:0036109) | 3.67282237 |
| 47 | quaternary ammonium group transport (GO:0015697) | 3.66235452 |
| 48 | focal adhesion assembly (GO:0048041) | 3.60394179 |
| 49 | cell-substrate adherens junction assembly (GO:0007045) | 3.60394179 |
| 50 | fatty acid oxidation (GO:0019395) | 3.60286365 |
| 51 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.58997492 |
| 52 | intracellular lipid transport (GO:0032365) | 3.57661917 |
| 53 | nuclear pore organization (GO:0006999) | 3.56676837 |
| 54 | lipid oxidation (GO:0034440) | 3.50738428 |
| 55 | succinate metabolic process (GO:0006105) | 3.50190592 |
| 56 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.49986745 |
| 57 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.47536298 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.45878182 |
| 59 | fatty acid catabolic process (GO:0009062) | 3.45585486 |
| 60 | actomyosin structure organization (GO:0031032) | 3.44627021 |
| 61 | oxaloacetate metabolic process (GO:0006107) | 3.43361639 |
| 62 | glycogen catabolic process (GO:0005980) | 3.41847913 |
| 63 | fatty acid homeostasis (GO:0055089) | 3.41838435 |
| 64 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.40445153 |
| 65 | heterochromatin organization (GO:0070828) | 3.40349752 |
| 66 | short-chain fatty acid metabolic process (GO:0046459) | 3.38483478 |
| 67 | NADH metabolic process (GO:0006734) | 3.37778963 |
| 68 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.36237869 |
| 69 | * regulation of coenzyme metabolic process (GO:0051196) | 3.34940451 |
| 70 | * regulation of cofactor metabolic process (GO:0051193) | 3.34940451 |
| 71 | amino-acid betaine metabolic process (GO:0006577) | 3.32753150 |
| 72 | striated muscle contraction (GO:0006941) | 3.31727790 |
| 73 | cardiac muscle cell development (GO:0055013) | 3.31466858 |
| 74 | adherens junction assembly (GO:0034333) | 3.30532268 |
| 75 | phospholipid homeostasis (GO:0055091) | 3.28579413 |
| 76 | histone lysine demethylation (GO:0070076) | 3.28319274 |
| 77 | carnitine metabolic process (GO:0009437) | 3.28278009 |
| 78 | glucan catabolic process (GO:0009251) | 3.27238398 |
| 79 | cardiac muscle hypertrophy (GO:0003300) | 3.24449968 |
| 80 | skeletal muscle adaptation (GO:0043501) | 3.19330716 |
| 81 | actin filament-based movement (GO:0030048) | 3.19197521 |
| 82 | mitotic chromosome condensation (GO:0007076) | 3.17825395 |
| 83 | DNA unwinding involved in DNA replication (GO:0006268) | 3.15735457 |
| 84 | histone H3-K4 trimethylation (GO:0080182) | 3.15121482 |
| 85 | striated muscle hypertrophy (GO:0014897) | 3.11941245 |
| 86 | cellular response to epidermal growth factor stimulus (GO:0071364) | 3.11596853 |
| 87 | chromosome condensation (GO:0030261) | 3.10933082 |
| 88 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.10157337 |
| 89 | negative regulation of cell size (GO:0045792) | 3.08549519 |
| 90 | cardiac cell development (GO:0055006) | 3.08306612 |
| 91 | regulation of relaxation of muscle (GO:1901077) | 3.08140618 |
| 92 | cellular polysaccharide catabolic process (GO:0044247) | 3.07187232 |
| 93 | regulation of actin filament-based movement (GO:1903115) | 3.06313177 |
| 94 | pore complex assembly (GO:0046931) | 3.05674224 |
| 95 | regulation of histone H3-K9 methylation (GO:0051570) | 3.04832694 |
| 96 | nucleosome disassembly (GO:0006337) | 3.03979610 |
| 97 | protein-DNA complex disassembly (GO:0032986) | 3.03979610 |
| 98 | histone demethylation (GO:0016577) | 3.03295333 |
| 99 | RNA stabilization (GO:0043489) | 3.01975134 |
| 100 | mRNA stabilization (GO:0048255) | 3.01975134 |
| 101 | monocarboxylic acid catabolic process (GO:0072329) | 3.00674497 |
| 102 | histone H3-K9 demethylation (GO:0033169) | 3.00375531 |
| 103 | TOR signaling (GO:0031929) | 2.99122512 |
| 104 | regulation of histone methylation (GO:0031060) | 2.98432871 |
| 105 | branched-chain amino acid metabolic process (GO:0009081) | 2.97998288 |
| 106 | peptidyl-lysine dimethylation (GO:0018027) | 2.97551437 |
| 107 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.93919405 |
| 108 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.93029966 |
| 109 | regulation of triglyceride catabolic process (GO:0010896) | 2.92876800 |
| 110 | regulation of cell communication by electrical coupling (GO:0010649) | 2.92472559 |
| 111 | skeletal muscle contraction (GO:0003009) | 2.91970915 |
| 112 | positive regulation of lipid catabolic process (GO:0050996) | 2.91379024 |
| 113 | G1 DNA damage checkpoint (GO:0044783) | 2.90600284 |
| 114 | polysaccharide catabolic process (GO:0000272) | 2.88027844 |
| 115 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.86300773 |
| 116 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.85006810 |
| 117 | response to epidermal growth factor (GO:0070849) | 2.84346624 |
| 118 | kynurenine metabolic process (GO:0070189) | 2.84071540 |
| 119 | * regulation of sulfur metabolic process (GO:0042762) | 2.81108188 |
| 120 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.80324596 |
| 121 | cell-substrate junction assembly (GO:0007044) | 2.78959312 |
| 122 | positive regulation of histone deacetylation (GO:0031065) | 2.78797154 |
| 123 | negative regulation of DNA repair (GO:0045738) | 2.78722646 |
| 124 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.77495654 |
| 125 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.76795727 |
| 126 | branched-chain amino acid catabolic process (GO:0009083) | 2.76215778 |
| 127 | striated muscle adaptation (GO:0014888) | 2.73698424 |
| 128 | regulation of DNA damage checkpoint (GO:2000001) | 2.73321975 |
| 129 | regulation of histone H3-K4 methylation (GO:0051569) | 2.73042182 |
| 130 | cellular ketone body metabolic process (GO:0046950) | 2.72965993 |
| 131 | chromatin silencing (GO:0006342) | 2.72295548 |
| 132 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.71539795 |
| 133 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.71408799 |
| 134 | * regulation of fatty acid metabolic process (GO:0019217) | 2.70326649 |
| 135 | paraxial mesoderm development (GO:0048339) | 2.69654886 |
| 136 | low-density lipoprotein particle clearance (GO:0034383) | 2.67865031 |
| 137 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.67829534 |
| 138 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.67295429 |
| 139 | muscle hypertrophy in response to stress (GO:0003299) | 2.67295429 |
| 140 | cardiac muscle adaptation (GO:0014887) | 2.67295429 |
| 141 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.67089867 |
| 142 | regulation of ARF GTPase activity (GO:0032312) | 2.66238900 |
| 143 | muscle hypertrophy (GO:0014896) | 2.64895795 |
| 144 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.64890463 |
| 145 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.64380794 |
| 146 | ethanol oxidation (GO:0006069) | 2.63968491 |
| 147 | glyoxylate metabolic process (GO:0046487) | 2.62572580 |
| 148 | protein demethylation (GO:0006482) | 2.60464327 |
| 149 | protein dealkylation (GO:0008214) | 2.60464327 |
| 150 | DNA packaging (GO:0006323) | 2.60135549 |
| 151 | definitive hemopoiesis (GO:0060216) | 2.58116161 |
| 152 | mitotic sister chromatid cohesion (GO:0007064) | 2.56658578 |
| 153 | mitotic G1/S transition checkpoint (GO:0044819) | 2.55962249 |
| 154 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.55936065 |
| 155 | DNA duplex unwinding (GO:0032508) | 2.55868666 |
| 156 | histone H3-K4 methylation (GO:0051568) | 2.55715204 |
| 157 | histone H3-K9 modification (GO:0061647) | 2.55250231 |
| 158 | embryonic process involved in female pregnancy (GO:0060136) | 2.54995322 |
| 159 | negative regulation of histone modification (GO:0031057) | 2.54601273 |
| 160 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.50518729 |
| 161 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.50047131 |
| 162 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.49403577 |
| 163 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.45759510 |
| 164 | histone lysine methylation (GO:0034968) | 2.45335675 |
| 165 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.43027149 |
| 166 | DNA conformation change (GO:0071103) | 2.43010928 |
| 167 | regulation of gene silencing by RNA (GO:0060966) | 2.42604090 |
| 168 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.42604090 |
| 169 | regulation of gene silencing by miRNA (GO:0060964) | 2.42604090 |
| 170 | DNA geometric change (GO:0032392) | 2.40774972 |
| 171 | histone H3-K9 methylation (GO:0051567) | 2.40768494 |
| 172 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.40558097 |
| 173 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.40558097 |
| 174 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.40558097 |
| 175 | histone H4 deacetylation (GO:0070933) | 2.39335730 |
| 176 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.38902157 |
| 177 | negative regulation of necroptotic process (GO:0060546) | 2.38777096 |
| 178 | DNA replication initiation (GO:0006270) | 2.38046195 |
| 179 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.37765279 |
| 180 | apoptotic process involved in morphogenesis (GO:0060561) | 2.36741616 |
| 181 | peptidyl-threonine phosphorylation (GO:0018107) | 2.36328867 |
| 182 | peptidyl-threonine modification (GO:0018210) | 2.35812676 |
| 183 | pinocytosis (GO:0006907) | 2.35454649 |
| 184 | histone deubiquitination (GO:0016578) | 2.34981495 |
| 185 | thymic T cell selection (GO:0045061) | 2.34920068 |
| 186 | cellular hyperosmotic response (GO:0071474) | 2.34117210 |
| 187 | positive regulation of catenin import into nucleus (GO:0035413) | 2.33332637 |
| 188 | protein export from nucleus (GO:0006611) | 2.30950870 |
| 189 | cortical actin cytoskeleton organization (GO:0030866) | 2.30813421 |
| 190 | negative regulation of granulocyte differentiation (GO:0030853) | 2.28644318 |
| 191 | stress granule assembly (GO:0034063) | 2.27862340 |
| 192 | cellular response to osmotic stress (GO:0071470) | 2.27236684 |
| 193 | peptidyl-lysine trimethylation (GO:0018023) | 2.24535558 |
| 194 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.24512740 |
| 195 | negative regulation of chromatin modification (GO:1903309) | 2.24436601 |
| 196 | negative regulation of viral release from host cell (GO:1902187) | 2.23956867 |
| 197 | regulation of necroptotic process (GO:0060544) | 2.23925226 |
| 198 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.23917302 |
| 199 | DNA synthesis involved in DNA repair (GO:0000731) | 2.22934631 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.03630553 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.58288055 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.15673935 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.73190690 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.61668435 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.55788940 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.39376506 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.11814276 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.00282165 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.58088998 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.51953999 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.44124928 |
| 13 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.36742807 |
| 14 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.36742807 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.31532391 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.27577877 |
| 17 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.25270545 |
| 18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.23563966 |
| 19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.10037656 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.05092663 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01982775 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00480577 |
| 23 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.95771489 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95589724 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.91522756 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.89562396 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.86372628 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.67809191 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66926829 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64857082 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63786879 |
| 32 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.60535222 |
| 33 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.59056339 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58277393 |
| 35 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.57509831 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.57032959 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55163888 |
| 38 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51775057 |
| 39 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51125098 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50473027 |
| 41 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50221876 |
| 42 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44762309 |
| 43 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.44204080 |
| 44 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.43955157 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.43186214 |
| 46 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42548323 |
| 47 | * MAF_26560356_Chip-Seq_TH2_Human | 1.42255571 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.41588441 |
| 49 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.40684281 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39815019 |
| 51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38460972 |
| 52 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.35187425 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35087013 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34460311 |
| 55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.32825697 |
| 56 | MYB_26560356_Chip-Seq_TH1_Human | 1.32389273 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31406693 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28129456 |
| 59 | MYC_22102868_ChIP-Seq_BL_Human | 1.26994423 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.26181644 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25389172 |
| 62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24478222 |
| 63 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.24413788 |
| 64 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.24000596 |
| 65 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.22881857 |
| 66 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21630933 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21401100 |
| 68 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.21324619 |
| 69 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20701336 |
| 70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20102328 |
| 71 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20048595 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19584466 |
| 73 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15742845 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15698674 |
| 75 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.15560605 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15557411 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15298745 |
| 78 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15113858 |
| 79 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15077702 |
| 80 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11512822 |
| 81 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11260502 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 1.10185531 |
| 83 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09801842 |
| 84 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09099897 |
| 85 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08660964 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08557447 |
| 87 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.08252147 |
| 88 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07631537 |
| 89 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07215422 |
| 90 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07142375 |
| 91 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.06909090 |
| 92 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.05234981 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04713660 |
| 94 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04475158 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04410623 |
| 96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03548771 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03516862 |
| 98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02978922 |
| 99 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02610388 |
| 100 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02570905 |
| 101 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.02544929 |
| 102 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02391524 |
| 103 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02269998 |
| 104 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02190540 |
| 105 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01921277 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01644678 |
| 107 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.00959115 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00486240 |
| 109 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00211236 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00189892 |
| 111 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99758398 |
| 112 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99687837 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99316758 |
| 114 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.98986442 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96746854 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.96614171 |
| 117 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96497159 |
| 118 | P68_20966046_ChIP-Seq_HELA_Human | 0.96477740 |
| 119 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.96053667 |
| 120 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95835891 |
| 121 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95542202 |
| 122 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95158695 |
| 123 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.94908643 |
| 124 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.94904692 |
| 125 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94407110 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94360168 |
| 127 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93082127 |
| 128 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92194305 |
| 129 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.92186408 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91877413 |
| 131 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.91405760 |
| 132 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91383442 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.91071368 |
| 134 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90690676 |
| 135 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.89732876 |
| 136 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89440408 |
| 137 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.89192145 |
| 138 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.88771297 |
| 139 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86370512 |
| 140 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86190022 |
| 141 | * MAF_26560356_Chip-Seq_TH1_Human | 0.86097993 |
| 142 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86073012 |
| 143 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84830400 |
| 144 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.84289719 |
| 145 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84099136 |
| 146 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84087454 |
| 147 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.83807138 |
| 148 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83429355 |
| 149 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.81732134 |
| 150 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80726743 |
| 151 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.80675874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.87950522 |
| 2 | MP0003646_muscle_fatigue | 4.85440936 |
| 3 | MP0004130_abnormal_muscle_cell | 3.89066228 |
| 4 | MP0000751_myopathy | 3.74637818 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.60214681 |
| 6 | MP0004084_abnormal_cardiac_muscle | 3.31788233 |
| 7 | MP0008057_abnormal_DNA_replication | 3.30411270 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.05950680 |
| 9 | MP0000749_muscle_degeneration | 3.05323525 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.84894280 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.84424175 |
| 12 | MP0004087_abnormal_muscle_fiber | 2.76027160 |
| 13 | MP0005330_cardiomyopathy | 2.69545896 |
| 14 | MP0004215_abnormal_myocardial_fiber | 2.69304299 |
| 15 | MP0005670_abnormal_white_adipose | 2.67521567 |
| 16 | MP0005360_urolithiasis | 2.58538605 |
| 17 | MP0004185_abnormal_adipocyte_glucose | 2.54478707 |
| 18 | MP0001849_ear_inflammation | 2.52497977 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 2.46753104 |
| 20 | MP0002269_muscular_atrophy | 2.46669805 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 2.44152362 |
| 22 | MP0005365_abnormal_bile_salt | 2.40061957 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 2.37526973 |
| 24 | MP0000747_muscle_weakness | 2.31196296 |
| 25 | MP0005409_darkened_coat_color | 2.29068734 |
| 26 | MP0003252_abnormal_bile_duct | 2.27746042 |
| 27 | MP0009278_abnormal_bone_marrow | 2.24788553 |
| 28 | MP0002106_abnormal_muscle_physiology | 2.20027474 |
| 29 | MP0002009_preneoplasia | 2.14352281 |
| 30 | MP0005620_abnormal_muscle_contractility | 2.09228164 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 2.08672093 |
| 32 | MP0003763_abnormal_thymus_physiology | 2.06770473 |
| 33 | MP0010630_abnormal_cardiac_muscle | 2.04338419 |
| 34 | MP0003111_abnormal_nucleus_morphology | 1.98969095 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.94897107 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.94092824 |
| 37 | MP0004233_abnormal_muscle_weight | 1.92976645 |
| 38 | MP0005375_adipose_tissue_phenotype | 1.92684721 |
| 39 | MP0000759_abnormal_skeletal_muscle | 1.91533094 |
| 40 | MP0002972_abnormal_cardiac_muscle | 1.82932680 |
| 41 | MP0005369_muscle_phenotype | 1.76778101 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.76701836 |
| 43 | MP0001544_abnormal_cardiovascular_syste | 1.74467195 |
| 44 | MP0005385_cardiovascular_system_phenoty | 1.74467195 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.72708338 |
| 46 | MP0004264_abnormal_extraembryonic_tissu | 1.70684001 |
| 47 | MP0008775_abnormal_heart_ventricle | 1.68774845 |
| 48 | MP0002971_abnormal_brown_adipose | 1.62057041 |
| 49 | MP0001730_embryonic_growth_arrest | 1.59162053 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.56572892 |
| 51 | MP0002254_reproductive_system_inflammat | 1.56457736 |
| 52 | MP0006138_congestive_heart_failure | 1.54711963 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.49792000 |
| 54 | MP0003137_abnormal_impulse_conducting | 1.48341686 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 1.42835237 |
| 56 | MP0004484_altered_response_of | 1.40891192 |
| 57 | MP0002086_abnormal_extraembryonic_tissu | 1.39880817 |
| 58 | MP0005380_embryogenesis_phenotype | 1.38621186 |
| 59 | MP0001672_abnormal_embryogenesis/_devel | 1.38621186 |
| 60 | MP0000428_abnormal_craniofacial_morphol | 1.34307524 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.31765502 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.26951192 |
| 63 | MP0000350_abnormal_cell_proliferation | 1.26525450 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.26454300 |
| 65 | MP0000609_abnormal_liver_physiology | 1.25637291 |
| 66 | MP0004272_abnormal_basement_membrane | 1.24266438 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.23909589 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.21875912 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.21875912 |
| 70 | MP0010094_abnormal_chromosome_stability | 1.21874404 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.21667117 |
| 72 | MP0002138_abnormal_hepatobiliary_system | 1.16164116 |
| 73 | MP0002332_abnormal_exercise_endurance | 1.15685906 |
| 74 | MP0004510_myositis | 1.14690300 |
| 75 | MP0003077_abnormal_cell_cycle | 1.13988806 |
| 76 | MP0000733_abnormal_muscle_development | 1.13561632 |
| 77 | MP0000537_abnormal_urethra_morphology | 1.13097408 |
| 78 | MP0005332_abnormal_amino_acid | 1.11885984 |
| 79 | MP0002249_abnormal_larynx_morphology | 1.10674033 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 1.10668747 |
| 81 | MP0002080_prenatal_lethality | 1.10627162 |
| 82 | MP0003045_fibrosis | 1.10021311 |
| 83 | MP0005621_abnormal_cell_physiology | 1.09310986 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.09181208 |
| 85 | MP0002925_abnormal_cardiovascular_devel | 1.08358640 |
| 86 | MP0004085_abnormal_heartbeat | 1.08277034 |
| 87 | MP0000569_abnormal_digit_pigmentation | 1.08186208 |
| 88 | MP0004197_abnormal_fetal_growth/weight/ | 1.08103144 |
| 89 | MP0005076_abnormal_cell_differentiation | 1.06667735 |
| 90 | MP0001697_abnormal_embryo_size | 1.04989969 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 1.04734443 |
| 92 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03660470 |
| 93 | MP0005334_abnormal_fat_pad | 1.03243954 |
| 94 | MP0010352_gastrointestinal_tract_polyps | 1.01804402 |
| 95 | MP0002108_abnormal_muscle_morphology | 1.00112912 |
| 96 | MP0009703_decreased_birth_body | 0.98655137 |
| 97 | MP0000266_abnormal_heart_morphology | 0.97941878 |
| 98 | MP0003115_abnormal_respiratory_system | 0.97323027 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.96525994 |
| 100 | MP0002085_abnormal_embryonic_tissue | 0.96426897 |
| 101 | MP0009840_abnormal_foam_cell | 0.96144928 |
| 102 | MP0001915_intracranial_hemorrhage | 0.95993914 |
| 103 | MP0001661_extended_life_span | 0.95726700 |
| 104 | MP0004381_abnormal_hair_follicle | 0.95694925 |
| 105 | MP0002084_abnormal_developmental_patter | 0.95552181 |
| 106 | MP0009115_abnormal_fat_cell | 0.94616915 |
| 107 | MP0002078_abnormal_glucose_homeostasis | 0.92294852 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.91827776 |
| 109 | MP0005187_abnormal_penis_morphology | 0.90179640 |
| 110 | MP0003693_abnormal_embryo_hatching | 0.89558635 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.89364994 |
| 112 | MP0000678_abnormal_parathyroid_gland | 0.89002731 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.88793880 |
| 114 | MP0003828_pulmonary_edema | 0.88584417 |
| 115 | MP0005410_abnormal_fertilization | 0.87670685 |
| 116 | MP0001666_abnormal_nutrient_absorption | 0.87423189 |
| 117 | MP0003941_abnormal_skin_development | 0.87173310 |
| 118 | MP0002398_abnormal_bone_marrow | 0.87154742 |
| 119 | MP0004957_abnormal_blastocyst_morpholog | 0.86922263 |
| 120 | MP0003950_abnormal_plasma_membrane | 0.86201347 |
| 121 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85139371 |
| 122 | MP0000566_synostosis | 0.84445498 |
| 123 | MP0003453_abnormal_keratinocyte_physiol | 0.83481866 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.82962757 |
| 125 | MP0000432_abnormal_head_morphology | 0.82937534 |
| 126 | MP0004947_skin_inflammation | 0.80106083 |
| 127 | MP0002006_tumorigenesis | 0.79247046 |
| 128 | MP0003566_abnormal_cell_adhesion | 0.78960943 |
| 129 | MP0001270_distended_abdomen | 0.78838914 |
| 130 | MP0002722_abnormal_immune_system | 0.78301308 |
| 131 | MP0008007_abnormal_cellular_replicative | 0.78130816 |
| 132 | MP0001614_abnormal_blood_vessel | 0.78070367 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.77633987 |
| 134 | MP0005266_abnormal_metabolism | 0.77289306 |
| 135 | MP0008438_abnormal_cutaneous_collagen | 0.77050515 |
| 136 | MP0003935_abnormal_craniofacial_develop | 0.75726924 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.75504649 |
| 138 | MP0005083_abnormal_biliary_tract | 0.74272052 |
| 139 | MP0005535_abnormal_body_temperature | 0.73653242 |
| 140 | MP0002970_abnormal_white_adipose | 0.71885516 |
| 141 | MP0002127_abnormal_cardiovascular_syste | 0.71834087 |
| 142 | MP0010234_abnormal_vibrissa_follicle | 0.71299507 |
| 143 | MP0002128_abnormal_blood_circulation | 0.68993325 |
| 144 | MP0003195_calcinosis | 0.68834191 |
| 145 | MP0009672_abnormal_birth_weight | 0.68413707 |
| 146 | MP0003984_embryonic_growth_retardation | 0.68399879 |
| 147 | MP0002088_abnormal_embryonic_growth/wei | 0.67998896 |
| 148 | MP0003191_abnormal_cellular_cholesterol | 0.66448855 |
| 149 | MP0002166_altered_tumor_susceptibility | 0.65016721 |
| 150 | MP0004147_increased_porphyrin_level | 0.63170123 |
| 151 | MP0006035_abnormal_mitochondrial_morpho | 0.61096387 |
| 152 | MP0005451_abnormal_body_composition | 0.58637054 |
| 153 | MP0003868_abnormal_feces_composition | 0.57866104 |
| 154 | MP0000598_abnormal_liver_morphology | 0.56333144 |
| 155 | MP0003091_abnormal_cell_migration | 0.54383914 |
| 156 | MP0004043_abnormal_pH_regulation | 0.53584002 |
| 157 | MP0010368_abnormal_lymphatic_system | 0.52708490 |
| 158 | MP0002168_other_aberrant_phenotype | 0.51667698 |
| 159 | MP0010307_abnormal_tumor_latency | 0.49129601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.92829721 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.26786704 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 5.10893634 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 4.89397831 |
| 5 | Myoglobinuria (HP:0002913) | 4.86625905 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.69937909 |
| 7 | Sudden death (HP:0001699) | 4.69617430 |
| 8 | Difficulty running (HP:0009046) | 4.37572963 |
| 9 | Muscle fiber splitting (HP:0003555) | 4.31651334 |
| 10 | Increased connective tissue (HP:0009025) | 4.10322101 |
| 11 | Rhabdomyolysis (HP:0003201) | 3.92599989 |
| 12 | Ventricular tachycardia (HP:0004756) | 3.73551713 |
| 13 | Muscle fiber inclusion bodies (HP:0100299) | 3.66417035 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 3.62719044 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 3.57581885 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.52486484 |
| 17 | Subaortic stenosis (HP:0001682) | 3.52486484 |
| 18 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.48118504 |
| 19 | EMG: myopathic abnormalities (HP:0003458) | 3.42879650 |
| 20 | Ketoacidosis (HP:0001993) | 3.21105063 |
| 21 | Lipoatrophy (HP:0100578) | 3.21053522 |
| 22 | Ketosis (HP:0001946) | 3.18230988 |
| 23 | Hyperglycinuria (HP:0003108) | 3.09715625 |
| 24 | Hyperacusis (HP:0010780) | 3.04917068 |
| 25 | Right ventricular cardiomyopathy (HP:0011663) | 3.01914945 |
| 26 | Bundle branch block (HP:0011710) | 2.98189427 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 2.97921068 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 2.95851278 |
| 29 | Hypoglycemic coma (HP:0001325) | 2.94663764 |
| 30 | Abnormality of the fingertips (HP:0001211) | 2.94039949 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.90460307 |
| 32 | Abnormality of glycine metabolism (HP:0010895) | 2.90460307 |
| 33 | Atrial fibrillation (HP:0005110) | 2.89854702 |
| 34 | Hyperammonemia (HP:0001987) | 2.85841701 |
| 35 | Nemaline bodies (HP:0003798) | 2.84945986 |
| 36 | Muscle stiffness (HP:0003552) | 2.82424384 |
| 37 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.80431373 |
| 38 | Difficulty climbing stairs (HP:0003551) | 2.70200629 |
| 39 | Intrahepatic cholestasis (HP:0001406) | 2.69299814 |
| 40 | Increased variability in muscle fiber diameter (HP:0003557) | 2.68401085 |
| 41 | Dilated cardiomyopathy (HP:0001644) | 2.66836295 |
| 42 | Primary atrial arrhythmia (HP:0001692) | 2.65812335 |
| 43 | Syringomyelia (HP:0003396) | 2.62204619 |
| 44 | Spinal cord lesions (HP:0100561) | 2.62204619 |
| 45 | Dysmetric saccades (HP:0000641) | 2.60412923 |
| 46 | Hyperglycinemia (HP:0002154) | 2.60406181 |
| 47 | Atrioventricular block (HP:0001678) | 2.58141296 |
| 48 | Myotonia (HP:0002486) | 2.55323745 |
| 49 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.53859241 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.52050716 |
| 51 | Toxemia of pregnancy (HP:0100603) | 2.50566017 |
| 52 | Asymmetry of the thorax (HP:0001555) | 2.49436100 |
| 53 | Broad face (HP:0000283) | 2.48926934 |
| 54 | Heart block (HP:0012722) | 2.46098587 |
| 55 | Supraventricular tachycardia (HP:0004755) | 2.45960560 |
| 56 | Round ear (HP:0100830) | 2.44378315 |
| 57 | Supraventricular arrhythmia (HP:0005115) | 2.42368620 |
| 58 | Frequent falls (HP:0002359) | 2.41358575 |
| 59 | Myopathic facies (HP:0002058) | 2.38327775 |
| 60 | Facial diplegia (HP:0001349) | 2.37502914 |
| 61 | EMG: neuropathic changes (HP:0003445) | 2.36545347 |
| 62 | Obstructive sleep apnea (HP:0002870) | 2.34364169 |
| 63 | Distal arthrogryposis (HP:0005684) | 2.34094629 |
| 64 | Heterotopia (HP:0002282) | 2.33803851 |
| 65 | Ventricular arrhythmia (HP:0004308) | 2.32888786 |
| 66 | Syncope (HP:0001279) | 2.29776199 |
| 67 | Abnormality of the thoracic spine (HP:0100711) | 2.29244735 |
| 68 | Long eyelashes (HP:0000527) | 2.28070930 |
| 69 | Ankyloglossia (HP:0010296) | 2.27136705 |
| 70 | Palpitations (HP:0001962) | 2.26682551 |
| 71 | Dislocated radial head (HP:0003083) | 2.25459243 |
| 72 | Abnormal atrioventricular conduction (HP:0005150) | 2.24355551 |
| 73 | Chromsome breakage (HP:0040012) | 2.24158646 |
| 74 | Abnormality of the columella (HP:0009929) | 2.23356650 |
| 75 | Cerebral aneurysm (HP:0004944) | 2.19668263 |
| 76 | Flat acetabular roof (HP:0003180) | 2.19279443 |
| 77 | Hypolipoproteinemia (HP:0010981) | 2.17308525 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.17223145 |
| 79 | Dicarboxylic aciduria (HP:0003215) | 2.17223145 |
| 80 | Rimmed vacuoles (HP:0003805) | 2.16477936 |
| 81 | Hypoplastic ischia (HP:0003175) | 2.16203983 |
| 82 | Hamartoma of the eye (HP:0010568) | 2.15831334 |
| 83 | Areflexia of lower limbs (HP:0002522) | 2.15381866 |
| 84 | Hyperglycemia (HP:0003074) | 2.15257108 |
| 85 | Thoracic kyphosis (HP:0002942) | 2.14050303 |
| 86 | Shallow orbits (HP:0000586) | 2.13360085 |
| 87 | Urethral obstruction (HP:0000796) | 2.12836521 |
| 88 | Proximal amyotrophy (HP:0007126) | 2.12800068 |
| 89 | Anteriorly placed anus (HP:0001545) | 2.12085590 |
| 90 | Deep venous thrombosis (HP:0002625) | 2.11962177 |
| 91 | Ulnar bowing (HP:0003031) | 2.11536606 |
| 92 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.07092172 |
| 93 | Limb-girdle muscle weakness (HP:0003325) | 2.05963621 |
| 94 | Narrow palate (HP:0000189) | 2.05800347 |
| 95 | Protrusio acetabuli (HP:0003179) | 2.03341722 |
| 96 | Xanthomatosis (HP:0000991) | 2.02174242 |
| 97 | Aortic aneurysm (HP:0004942) | 2.01520095 |
| 98 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.00413202 |
| 99 | Abnormality of the radial head (HP:0003995) | 1.99858192 |
| 100 | Limb-girdle muscle atrophy (HP:0003797) | 1.95451784 |
| 101 | Abnormality of the ischium (HP:0003174) | 1.95442976 |
| 102 | Abnormality of oral frenula (HP:0000190) | 1.95258059 |
| 103 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.93311632 |
| 104 | Prolonged QT interval (HP:0001657) | 1.92788181 |
| 105 | Scapular winging (HP:0003691) | 1.91825499 |
| 106 | Epidermoid cyst (HP:0200040) | 1.91655214 |
| 107 | Renovascular hypertension (HP:0100817) | 1.90166598 |
| 108 | Lymphangioma (HP:0100764) | 1.87295550 |
| 109 | Ulnar deviation of the wrist (HP:0003049) | 1.87117271 |
| 110 | Disproportionate tall stature (HP:0001519) | 1.86120812 |
| 111 | Neck muscle weakness (HP:0000467) | 1.85648227 |
| 112 | High anterior hairline (HP:0009890) | 1.85336818 |
| 113 | Bronchomalacia (HP:0002780) | 1.85120655 |
| 114 | Spinal rigidity (HP:0003306) | 1.83648569 |
| 115 | Abnormality of the salivary glands (HP:0010286) | 1.83635973 |
| 116 | Conjunctival hamartoma (HP:0100780) | 1.83383359 |
| 117 | Subacute progressive viral hepatitis (HP:0006572) | 1.83268119 |
| 118 | Turricephaly (HP:0000262) | 1.83132047 |
| 119 | Cholelithiasis (HP:0001081) | 1.82861484 |
| 120 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.82445494 |
| 121 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.81909061 |
| 122 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.81257859 |
| 123 | Abnormality of cochlea (HP:0000375) | 1.80296221 |
| 124 | Trigonocephaly (HP:0000243) | 1.80231009 |
| 125 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.79934250 |
| 126 | Abnormal ossification of hand bones (HP:0005921) | 1.77373333 |
| 127 | Germ cell neoplasia (HP:0100728) | 1.77362734 |
| 128 | Colitis (HP:0002583) | 1.77331558 |
| 129 | Skull defect (HP:0001362) | 1.77217051 |
| 130 | Thin ribs (HP:0000883) | 1.75441414 |
| 131 | Abnormality of the lumbar spine (HP:0100712) | 1.75166638 |
| 132 | Arnold-Chiari malformation (HP:0002308) | 1.74882269 |
| 133 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.72465772 |
| 134 | Broad palm (HP:0001169) | 1.72316126 |
| 135 | Skin nodule (HP:0200036) | 1.71388217 |
| 136 | Elfin facies (HP:0004428) | 1.70587586 |
| 137 | Aneurysm (HP:0002617) | 1.70523656 |
| 138 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.70161509 |
| 139 | Abnormality of the humeroradial joint (HP:0100744) | 1.70059620 |
| 140 | Prominent nose (HP:0000448) | 1.69102351 |
| 141 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.68940613 |
| 142 | Advanced eruption of teeth (HP:0006288) | 1.68816294 |
| 143 | Overriding aorta (HP:0002623) | 1.68078773 |
| 144 | Abnormality of the lower motor neuron (HP:0002366) | 1.67822087 |
| 145 | Abnormality of carpal bone ossification (HP:0006257) | 1.67368836 |
| 146 | Insomnia (HP:0100785) | 1.67159981 |
| 147 | Lower limb amyotrophy (HP:0007210) | 1.66407503 |
| 148 | Bowel incontinence (HP:0002607) | 1.66265613 |
| 149 | Long palpebral fissure (HP:0000637) | 1.65984105 |
| 150 | Esophageal neoplasm (HP:0100751) | 1.65964125 |
| 151 | Neoplasm of head and neck (HP:0012288) | 1.65964125 |
| 152 | Resting tremor (HP:0002322) | 1.65875910 |
| 153 | Ventricular fibrillation (HP:0001663) | 1.65534777 |
| 154 | Abnormality of the Achilles tendon (HP:0005109) | 1.64667918 |
| 155 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.64610198 |
| 156 | Hyperkalemia (HP:0002153) | 1.64497184 |
| 157 | Patellar dislocation (HP:0002999) | 1.64142419 |
| 158 | Muscular dystrophy (HP:0003560) | 1.62863135 |
| 159 | Broad metatarsal (HP:0001783) | 1.62736487 |
| 160 | Slender build (HP:0001533) | 1.62692712 |
| 161 | Flat cornea (HP:0007720) | 1.62227667 |
| 162 | Persistence of primary teeth (HP:0006335) | 1.61498603 |
| 163 | Wide nose (HP:0000445) | 1.61304023 |
| 164 | Oligomenorrhea (HP:0000876) | 1.60940741 |
| 165 | Capillary hemangiomas (HP:0005306) | 1.59359436 |
| 166 | Renal duplication (HP:0000075) | 1.58810283 |
| 167 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.58703133 |
| 168 | Mitral valve prolapse (HP:0001634) | 1.57967410 |
| 169 | Acute myeloid leukemia (HP:0004808) | 1.57673563 |
| 170 | Biconcave vertebral bodies (HP:0004586) | 1.57076459 |
| 171 | Increased nuchal translucency (HP:0010880) | 1.56604112 |
| 172 | Pointed chin (HP:0000307) | 1.56094173 |
| 173 | Broad thumb (HP:0011304) | 1.56011114 |
| 174 | Progressive muscle weakness (HP:0003323) | 1.55071303 |
| 175 | Deep palmar crease (HP:0006191) | 1.55025900 |
| 176 | Abnormal foot bone ossification (HP:0010675) | 1.52918785 |
| 177 | Sandal gap (HP:0001852) | 1.51622677 |
| 178 | High pitched voice (HP:0001620) | 1.51008414 |
| 179 | Basal cell carcinoma (HP:0002671) | 1.50677394 |
| 180 | Acute lymphatic leukemia (HP:0006721) | 1.50557736 |
| 181 | Relative macrocephaly (HP:0004482) | 1.49662450 |
| 182 | Abnormal large intestine physiology (HP:0012700) | 1.46620024 |
| 183 | Vertebral arch anomaly (HP:0008438) | 1.44696997 |
| 184 | Small epiphyses (HP:0010585) | 1.40973762 |
| 185 | Abnormal tarsal ossification (HP:0008369) | 1.40882267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.59274135 |
| 2 | OBSCN | 3.53306682 |
| 3 | TRIB3 | 3.45010786 |
| 4 | PKN2 | 3.42514695 |
| 5 | SMG1 | 3.12561210 |
| 6 | PRPF4B | 2.84059574 |
| 7 | PDK3 | 2.83443592 |
| 8 | PDK4 | 2.83443592 |
| 9 | PHKG2 | 2.65960117 |
| 10 | PHKG1 | 2.65960117 |
| 11 | DMPK | 2.47805424 |
| 12 | BRD4 | 2.42266073 |
| 13 | STK3 | 2.40039683 |
| 14 | BCKDK | 2.33966023 |
| 15 | LMTK2 | 2.18436246 |
| 16 | RIPK1 | 2.17462562 |
| 17 | SIK1 | 2.12871181 |
| 18 | STK24 | 2.12149524 |
| 19 | LATS1 | 2.06539424 |
| 20 | EEF2K | 1.88516812 |
| 21 | MAP3K13 | 1.86195346 |
| 22 | CDK12 | 1.80490623 |
| 23 | CAMK1D | 1.75543735 |
| 24 | NEK1 | 1.61510119 |
| 25 | MAP3K7 | 1.60943136 |
| 26 | PTK6 | 1.49182593 |
| 27 | PDK2 | 1.45737003 |
| 28 | MAP3K10 | 1.43169332 |
| 29 | CAMK1G | 1.43155136 |
| 30 | MARK3 | 1.40839745 |
| 31 | FLT3 | 1.30835487 |
| 32 | RPS6KB2 | 1.30341368 |
| 33 | FGFR4 | 1.23612958 |
| 34 | NLK | 1.23060060 |
| 35 | PDGFRA | 1.21017747 |
| 36 | LATS2 | 1.19754905 |
| 37 | PRKAA1 | 1.18950265 |
| 38 | PIK3CA | 1.18264484 |
| 39 | FGFR3 | 1.15509690 |
| 40 | PRKAA2 | 1.12101963 |
| 41 | SGK3 | 1.10061621 |
| 42 | PLK4 | 1.09762136 |
| 43 | MAP2K3 | 1.07023169 |
| 44 | MTOR | 1.06782525 |
| 45 | NEK2 | 1.06611094 |
| 46 | MAP4K1 | 0.98788278 |
| 47 | RET | 0.98566372 |
| 48 | INSRR | 0.97581215 |
| 49 | SIK2 | 0.97263699 |
| 50 | ZAP70 | 0.97184727 |
| 51 | WNK1 | 0.94001670 |
| 52 | PINK1 | 0.93330648 |
| 53 | CDC7 | 0.89454768 |
| 54 | MAP3K1 | 0.87711958 |
| 55 | JAK1 | 0.85412228 |
| 56 | MAP2K4 | 0.82590049 |
| 57 | PDGFRB | 0.81684025 |
| 58 | HIPK2 | 0.79767789 |
| 59 | PAK3 | 0.78913645 |
| 60 | CDK6 | 0.76706517 |
| 61 | TYK2 | 0.76101435 |
| 62 | CDK3 | 0.76055879 |
| 63 | CDK7 | 0.76029937 |
| 64 | RIPK4 | 0.75963778 |
| 65 | CDK4 | 0.75411636 |
| 66 | SGK494 | 0.75189024 |
| 67 | SGK223 | 0.75189024 |
| 68 | ICK | 0.72781056 |
| 69 | FRK | 0.71645152 |
| 70 | STK38 | 0.71495887 |
| 71 | CDK8 | 0.71445515 |
| 72 | STK4 | 0.69758080 |
| 73 | SGK2 | 0.68561888 |
| 74 | CLK1 | 0.68209039 |
| 75 | MAP3K4 | 0.67927303 |
| 76 | MAPK12 | 0.67784528 |
| 77 | PRKD1 | 0.67654022 |
| 78 | FGFR1 | 0.65592273 |
| 79 | STK10 | 0.64875367 |
| 80 | ALK | 0.63132412 |
| 81 | MAP3K14 | 0.62544903 |
| 82 | RPS6KB1 | 0.62530454 |
| 83 | PDK1 | 0.61829375 |
| 84 | MAPK11 | 0.61428838 |
| 85 | MAP3K8 | 0.61139378 |
| 86 | AKT3 | 0.60712305 |
| 87 | FGFR2 | 0.60656005 |
| 88 | MYLK | 0.59512122 |
| 89 | PAK2 | 0.58739434 |
| 90 | RPS6KC1 | 0.57712535 |
| 91 | RPS6KL1 | 0.57712535 |
| 92 | TAOK3 | 0.57665999 |
| 93 | BTK | 0.56707135 |
| 94 | PRKD2 | 0.56602103 |
| 95 | JAK2 | 0.56038720 |
| 96 | STK38L | 0.53637687 |
| 97 | LRRK2 | 0.53374328 |
| 98 | PASK | 0.53326349 |
| 99 | TAOK1 | 0.52835130 |
| 100 | MAP3K5 | 0.51556759 |
| 101 | TRPM7 | 0.51106766 |
| 102 | MAPK10 | 0.50883547 |
| 103 | ROCK1 | 0.49869375 |
| 104 | EPHB1 | 0.49570148 |
| 105 | TTK | 0.49210877 |
| 106 | CAMK4 | 0.49187523 |
| 107 | MAP2K2 | 0.48565467 |
| 108 | CHEK1 | 0.48547239 |
| 109 | AKT2 | 0.48143990 |
| 110 | NEK9 | 0.47916003 |
| 111 | PRKCH | 0.47705837 |
| 112 | MAPK7 | 0.47355379 |
| 113 | CDK9 | 0.46869118 |
| 114 | RAF1 | 0.45681662 |
| 115 | PDPK1 | 0.44163951 |
| 116 | KSR2 | 0.43836710 |
| 117 | PRKD3 | 0.41771004 |
| 118 | YES1 | 0.41164334 |
| 119 | CDK2 | 0.40781897 |
| 120 | SGK1 | 0.39753942 |
| 121 | HCK | 0.39098279 |
| 122 | NEK6 | 0.38548010 |
| 123 | MAPK1 | 0.37623571 |
| 124 | PIK3CG | 0.37340076 |
| 125 | SCYL2 | 0.37049243 |
| 126 | STK11 | 0.36032860 |
| 127 | TYRO3 | 0.35480380 |
| 128 | JAK3 | 0.34944300 |
| 129 | MARK2 | 0.34550694 |
| 130 | RPS6KA3 | 0.34522090 |
| 131 | RPS6KA2 | 0.34514118 |
| 132 | MAP3K6 | 0.34324397 |
| 133 | PRKACG | 0.34133136 |
| 134 | RPS6KA1 | 0.32387904 |
| 135 | ITK | 0.32025772 |
| 136 | PAK6 | 0.30732874 |
| 137 | ERN1 | 0.30335646 |
| 138 | MELK | 0.29845279 |
| 139 | MAP3K9 | 0.29672603 |
| 140 | PRKACB | 0.28125715 |
| 141 | CSNK1D | 0.27598734 |
| 142 | TIE1 | 0.26806371 |
| 143 | BMX | 0.26062521 |
| 144 | CDC42BPA | 0.25878670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.99449572 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.60930910 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.48998613 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.36787443 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.29099972 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.74059708 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65703661 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.63950886 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33650097 |
| 10 | Carbon metabolism_Homo sapiens_hsa01200 | 2.13943631 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.12793271 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.12181613 |
| 13 | Thyroid cancer_Homo sapiens_hsa05216 | 2.00088053 |
| 14 | Lysine degradation_Homo sapiens_hsa00310 | 1.97649537 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85827087 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77327490 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.76527697 |
| 18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.74485851 |
| 19 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.73877068 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.73208841 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71257623 |
| 22 | Prostate cancer_Homo sapiens_hsa05215 | 1.66092796 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64082477 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.58397452 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58118337 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49398797 |
| 27 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42578568 |
| 28 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.40390960 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37183265 |
| 30 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33950060 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33929599 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.32787398 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.32282406 |
| 34 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.30987023 |
| 35 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29595262 |
| 36 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.29559533 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.27720413 |
| 38 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.25284526 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24654071 |
| 40 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.24068972 |
| 41 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.23011951 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22438105 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.22260683 |
| 44 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.19762705 |
| 45 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19451653 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.15924312 |
| 47 | Bladder cancer_Homo sapiens_hsa05219 | 1.15914546 |
| 48 | Colorectal cancer_Homo sapiens_hsa05210 | 1.15200421 |
| 49 | Hepatitis B_Homo sapiens_hsa05161 | 1.14809114 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.09672461 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06010613 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05770235 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 1.05083742 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.04952514 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03391414 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03117018 |
| 57 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02213040 |
| 58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.00602117 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99510473 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.97267350 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.94543880 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.93275749 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93233115 |
| 64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.91082347 |
| 65 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89149237 |
| 66 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.88827526 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.88814216 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.87803897 |
| 69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87263002 |
| 70 | Cell cycle_Homo sapiens_hsa04110 | 0.87118224 |
| 71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.84698155 |
| 72 | Long-term potentiation_Homo sapiens_hsa04720 | 0.84131494 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83728111 |
| 74 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83246136 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82236338 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81763007 |
| 77 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81245708 |
| 78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80876673 |
| 79 | Measles_Homo sapiens_hsa05162 | 0.80308994 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.79338209 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78434607 |
| 82 | Apoptosis_Homo sapiens_hsa04210 | 0.77985848 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77160552 |
| 84 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76872432 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76741528 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.76523108 |
| 87 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74145581 |
| 88 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73979416 |
| 89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.72509207 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72243464 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72138287 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72127962 |
| 93 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71165647 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70777815 |
| 95 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70099000 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68319434 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.67996874 |
| 98 | Melanoma_Homo sapiens_hsa05218 | 0.67945488 |
| 99 | Pathways in cancer_Homo sapiens_hsa05200 | 0.65956994 |
| 100 | DNA replication_Homo sapiens_hsa03030 | 0.65456125 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64883946 |
| 102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61330321 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.60314240 |
| 104 | Gap junction_Homo sapiens_hsa04540 | 0.60244278 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59434197 |
| 106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58690320 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58297823 |
| 108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58277167 |
| 109 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.56914098 |
| 110 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56818543 |
| 111 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56166431 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54770314 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52819814 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52384379 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | 0.52380893 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50144153 |
| 117 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49932909 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49675760 |
| 119 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49660540 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49567753 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49448947 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48447164 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.47310097 |
| 124 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43810653 |
| 125 | Renin secretion_Homo sapiens_hsa04924 | 0.42558390 |
| 126 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.41883561 |
| 127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41658479 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41031803 |
| 129 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39814682 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37373003 |
| 131 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36592270 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35615592 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35477160 |
| 134 | Amoebiasis_Homo sapiens_hsa05146 | 0.35029737 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32092679 |
| 136 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.31372884 |
| 137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30221035 |
| 138 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.26758392 |
| 139 | Platelet activation_Homo sapiens_hsa04611 | 0.25467318 |
| 140 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23939208 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.23408617 |
| 142 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23403526 |
| 143 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.23184674 |
| 144 | Glioma_Homo sapiens_hsa05214 | 0.22858184 |
| 145 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.22524717 |
| 146 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22315637 |
| 147 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.21708353 |
| 148 | Tight junction_Homo sapiens_hsa04530 | 0.21515683 |
| 149 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.21330597 |
| 150 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.21322142 |
| 151 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.21153912 |
| 152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21062261 |
| 153 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.20683803 |
| 154 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.19719502 |
| 155 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.19452618 |
| 156 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.19433224 |
| 157 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19118538 |
| 158 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18896319 |

